Market Closed -
OTC Markets
20:59:00 17/05/2024 BST
|
5-day change
|
1st Jan Change
|
0.28
USD
|
+1.78%
|
|
-6.64%
|
-37.75%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
538.3
|
1,756
|
1,076
|
309.3
|
193.5
|
341.2
|
-
|
-
|
Enterprise Value (EV)
1 |
497.1
|
1,991
|
1,415
|
828.4
|
704.1
|
830.7
|
787.5
|
341.2
|
P/E ratio
|
-5.08
x
|
-12.6
x
|
-6.81
x
|
-0.71
x
|
-1.05
x
|
-1.42
x
|
-3.73
x
|
5.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.95
x
|
9.78
x
|
2.27
x
|
0.6
x
|
0.38
x
|
0.67
x
|
0.59
x
|
0.49
x
|
EV / Revenue
|
6.42
x
|
11.1
x
|
2.99
x
|
1.62
x
|
1.38
x
|
1.64
x
|
1.36
x
|
0.49
x
|
EV / EBITDA
|
-10.6
x
|
-481
x
|
16.6
x
|
12.3
x
|
10.1
x
|
11.1
x
|
7.54
x
|
2.99
x
|
EV / FCF
|
-3.62
x
|
-23.3
x
|
-12
x
|
-4.5
x
|
-282
x
|
9.66
x
|
-
|
-
|
FCF Yield
|
-27.6%
|
-4.29%
|
-8.34%
|
-22.2%
|
-0.35%
|
10.4%
|
-
|
-
|
Price to Book
|
-
|
4.9
x
|
1.76
x
|
-
|
2.81
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
216,199
|
290,319
|
376,209
|
412,452
|
430,221
|
1,218,727
|
-
|
-
|
Reference price
2 |
2.490
|
6.050
|
2.860
|
0.7500
|
0.4498
|
0.2800
|
0.2800
|
0.2800
|
Announcement Date
|
10/03/20
|
03/03/21
|
14/03/22
|
29/03/23
|
13/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
77.46
|
179.5
|
473.8
|
511.6
|
511.3
|
507.3
|
577.4
|
689.7
|
EBITDA
1 |
-46.94
|
-4.138
|
85.07
|
67.38
|
69.64
|
74.83
|
104.4
|
114.2
|
EBIT
1 |
-92.89
|
-74.1
|
-110.4
|
-113.5
|
-105.2
|
-1.392
|
38.34
|
59.9
|
Operating Margin
|
-119.92%
|
-41.28%
|
-23.29%
|
-22.18%
|
-20.58%
|
-0.27%
|
6.64%
|
8.68%
|
Earnings before Tax (EBT)
1 |
-
|
-136.9
|
-146.7
|
-432.7
|
-168.9
|
-51.78
|
-14.43
|
28.6
|
Net income
1 |
-102.6
|
-110.8
|
-143.1
|
-416
|
-175.7
|
-92.94
|
-46.04
|
21
|
Net margin
|
-132.44%
|
-61.71%
|
-30.2%
|
-81.32%
|
-34.36%
|
-18.32%
|
-7.97%
|
3.04%
|
EPS
2 |
-0.4900
|
-0.4800
|
-0.4200
|
-1.060
|
-0.4300
|
-0.1972
|
-0.0750
|
0.0500
|
Free Cash Flow
1 |
-137.2
|
-85.49
|
-118
|
-184.1
|
-2.495
|
86.04
|
-
|
-
|
FCF margin
|
-177.11%
|
-47.63%
|
-24.91%
|
-35.99%
|
-0.49%
|
16.96%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
114.97%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/03/20
|
03/03/21
|
14/03/22
|
29/03/23
|
13/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
139.3
|
123.1
|
129.6
|
132.7
|
126.2
|
124.5
|
129.2
|
129.2
|
128.4
|
122.6
|
125.2
|
126.9
|
130.2
|
131.6
|
138
|
EBITDA
1 |
27.21
|
16.83
|
12.03
|
20.99
|
17.4
|
16.36
|
20.32
|
20.49
|
12.47
|
15.3
|
17.65
|
19.33
|
21.14
|
25.9
|
27.6
|
EBIT
1 |
-84.84
|
-14.66
|
-22.11
|
-18.71
|
-58
|
-8.269
|
0.049
|
-19.33
|
-77.69
|
-10.74
|
-2.073
|
0.0212
|
2.96
|
0.9
|
5.3
|
Operating Margin
|
-60.92%
|
-11.91%
|
-17.06%
|
-14.1%
|
-45.96%
|
-6.64%
|
0.04%
|
-14.96%
|
-60.52%
|
-8.76%
|
-1.66%
|
0.02%
|
2.27%
|
0.68%
|
3.84%
|
Earnings before Tax (EBT)
1 |
-53.89
|
-27.27
|
-35.55
|
-31.73
|
-338.1
|
-25.88
|
-22.73
|
-33.88
|
-86.4
|
-25.7
|
-17.03
|
-14.86
|
-11.92
|
-14
|
-9.7
|
Net income
1 |
-53.28
|
-26.64
|
-53.83
|
-35.43
|
-300.1
|
-37.34
|
-28.86
|
-36.72
|
-72.78
|
-35.07
|
-26.05
|
-24.35
|
-21.92
|
-25.1
|
-21.8
|
Net margin
|
-38.25%
|
-21.64%
|
-41.54%
|
-26.69%
|
-237.83%
|
-29.98%
|
-22.33%
|
-28.43%
|
-56.7%
|
-28.61%
|
-20.82%
|
-19.19%
|
-16.84%
|
-19.07%
|
-15.8%
|
EPS
2 |
-0.1400
|
-0.0700
|
-0.1400
|
-0.0900
|
-0.7500
|
-0.0900
|
-0.0700
|
-0.0900
|
-0.1800
|
-0.0800
|
-0.0435
|
-0.0395
|
-0.0345
|
-0.0600
|
-0.0500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/03/22
|
16/05/22
|
15/08/22
|
14/11/22
|
29/03/23
|
15/05/23
|
14/08/23
|
14/11/23
|
13/03/24
|
09/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
234
|
339
|
519
|
511
|
490
|
446
|
-
|
Net Cash position
1 |
41.3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-56.57
x
|
3.987
x
|
7.704
x
|
7.331
x
|
6.541
x
|
4.273
x
|
-
|
Free Cash Flow
1 |
-137
|
-85.5
|
-118
|
-184
|
-2.5
|
86
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-43.6%
|
-25.3%
|
-32.6%
|
-30.9%
|
-
|
-17.5%
|
128%
|
-
|
ROA (Net income/ Total Assets)
|
-32.3%
|
-12.7%
|
-13.6%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
318.1
|
873.3
|
1,052
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
1.240
|
1.630
|
-
|
0.1600
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-0.2800
|
-0.1800
|
-
|
-
|
-
|
0.0600
|
0.1800
|
-
|
Capex
1 |
77.4
|
42.9
|
118
|
72.7
|
9.97
|
18.1
|
-
|
-
|
Capex / Sales
|
99.98%
|
23.89%
|
24.8%
|
14.22%
|
1.95%
|
3.56%
|
-
|
-
|
Announcement Date
|
10/03/20
|
03/03/21
|
14/03/22
|
29/03/23
|
13/03/24
|
-
|
-
|
-
|
Last Close Price
0.28
USD Average target price
1.038
USD Spread / Average Target +270.71% Consensus |
1st Jan change
|
Capi.
|
---|
| -37.75% | 341M | | -.--% | 339M | | +52.26% | 299M | | +35.05% | 279M | | +57.56% | 206M | | +52.17% | 138M | | +140.77% | 137M | | +34.62% | 118M | | -28.57% | 122M | | +100.00% | 60.26M |
Medical Farming
|